So-called transient ischemic attacks can eventually lead to cognitive declines as steep as those following a full-on stroke, new research finds.
New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way.
The most extensive research on Medicaid coverage to date found that it reduced the risk of death by 21 percent.